XERS
Xeris Biopharma Holdings, Inc.
16.65
USD
This page is just a preview of the data found in TrendSpider’s full version
Xeris Biopharma Holdings, Inc. stock is up 61.49% since 30 days ago. The next earnings date is Mar 1, 2027. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 55.56% of the previous 8 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 10 CALLs. 67% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 16 Oct 19:55 | 16 Oct, 2026 | 7.50 | 1653 | ||
| 16 Oct 19:58 | 16 Oct, 2026 | 2.50 | 1194 | ||
| 30 Oct 16:11 | 16 Apr, 2027 | 10.00 | 304 | ||
| 05 Nov 14:30 | 16 Apr, 2027 | 7.50 | 201 | ||
| 06 Nov 16:38 | 16 Apr, 2027 | 14.00 | 61 | ||
| 09 Nov 15:37 | 16 Apr, 2027 | 10.00 | 483 | ||
| 09 Nov 16:34 | 16 Apr, 2027 | 14.00 | 239 | ||
| 13 Nov 17:39 | 20 Nov, 2026 | 2.50 | 195 | ||
| 13 Nov 17:42 | 20 Nov, 2026 | 2.50 | 195 | ||
| 13 Nov 17:55 | 20 Nov, 2026 | 2.50 | 195 |
-
OppenheimerFri Nov 6, 18:32
-
Piper SandlerFri Nov 6, 15:28
-
HC Wainwright & Co.Fri Nov 6, 12:52
-
Kevin McCulloch, See Remarksshares sold
-
Steven Pieper, See Remarksshares sold
-
Beth Hecht, See Remarksshares sold
-
Kevin McCulloch, See Remarksshares sold
-
Menassie Taddese, Directorshares awarded
-
Menassie Taddese, Directorshares awarded
Looking for a new broker?
Today’s Movers and Shakers
Join Our Market Watch Newsletter!
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!